Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | NAAA | Q02083 | 1/20 | 0.52 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1691906 | 1.00 | TSHR (0.61) | TSHRTHRBMEN1KMT2ANAAA | |
| SCHEMBL9206028 | 1.00 | TSHR (0.61) | TSHRTHRBMEN1KMT2ANAAA | |
| SCHEMBL4399689 | 1.00 | TSHR (0.61) | TSHRTHRBMEN1KMT2ANAAA | |
| SCHEMBL7699808 | 1.00 | TSHR (0.61) | TSHRTHRBMEN1KMT2ANAAA | |
| SCHEMBL107940 | 1.00 | TSHR (0.61) | TSHRTHRBMEN1KMT2ANAAA | |
| SCHEMBL4389498 | 1.00 | TSHR (0.61) | TSHRTHRBMEN1KMT2ANAAA | |
| SCHEMBL7697182 | 1.00 | TSHR (0.61) | TSHRTHRBMEN1KMT2ANAAA | |
| SCHEMBL95733 | 1.00 | TSHR (0.61) | TSHRTHRBMEN1KMT2ANAAA | |
| SCHEMBL277225 | 1.00 | TSHR (0.61) | TSHRTHRBMEN1KMT2ANAAA | |
| SCHEMBL4395275 | 1.00 | TSHR (0.61) | TSHRTHRBMEN1KMT2ANAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 334 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024125597-A1 | COMPOSITIONS AND METHODS FOR INFECTIOUS DISEASES | PROVIDENCE THERAPEUTICS HOLDINGS INC. (CA) | 2024-06-20 | — | — | WO | disclosed |
| US-12006423-B2 | Methods of making polymer compositions with enhanced elasticity by employing VTP and HMP catalyst systems in parallel processes | ExxonMobil Engineering & Technology Company (US) | 2024-06-11 | — | — | US | disclosed |
| CN-116157473-B | Method for manufacturing substrate with organic functional film | 日产化学株式会社 | 2024-05-10 | — | — | CN | disclosed |
| WO-2024057957-A1 | PHOTOELECTRIC CONVERSION ELEMENT MATERIAL, AND PHOTOELECTRIC CONVERSION ELEMENT USING SAME | 日鉄ケミカル＆マテリアル株式会社 | 2024-03-21 | — | — | WO | disclosed |
| US-20240092810-A1 | COMPOSITIONS FOR EXTREME ULTRAVIOLET LITHOGRAPHY AND RELATED METHODS | ENTEGRIS, INC. | 2024-03-21 | — | — | US | disclosed |
| WO-2024049919-A1 | COMPOSITIONS FOR EXTREME ULTRAVIOLET LITHOGRAPHY AND RELATED METHODS | ENTEGRIS, INC. (US) | 2024-03-07 | — | — | WO | disclosed |
| CN-112805329-B | Process for preparing polymer compositions with enhanced elasticity by employing VTP and HMP catalyst systems in parallel process | 埃克森美孚化学专利公司 | 2024-02-02 | — | — | CN | disclosed |
| EP-3841168-B1 | METHODS OF MAKING POLYMER COMPOSITIONS WITH ENHANCED ELASTICITY BY EMPLOYING VTP AND HMP CATALYST SYSTEMS IN PARALLEL PROCESSES | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2024-01-17 | — | — | EP | disclosed |
| CN-111836816-B | Aniline derivatives and use thereof | 日产化学株式会社 | 2023-12-19 | — | — | CN | disclosed |
| CN-117121652-A | Charge-transporting varnish | 日产化学株式会社 | 2023-11-24 | — | — | CN | disclosed |
| US-5344465-A | Azo pigment and basic dye, offset printing | BASF AKTIENGESELLSCHAFT (DE) | 1994-09-06 | — | — | US | disclosed |
| EP-0313965-B1 | Process for the manufacture of dihydroquinacridones, of quinacridones and of quinacridone quinones | BASF AG (DE) | 1994-03-16 | — | — | EP | disclosed |
| EP-0564237-A2 | Preparation of color filter and photo-setting resin therefor | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1993-10-06 | — | — | EP | disclosed |
| US-5214146-A | Color formers for pressure sensitive recording materials | BASF AKTIENGESELLSCHAFT (DE) | 1993-05-25 | — | — | US | disclosed |
| EP-0519423-A2 | Phthalocyanine compounds and usage thereof | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1992-12-23 | — | — | EP | disclosed |
| EP-0490200-A1 | Derivatives of quinoline carboxylic acid | BASF Aktiengesellschaft (DE) | 1992-06-17 | — | — | EP | disclosed |
| US-4956464-A | Cyclization, dehydrogenation in the vapor phase or solid phase in the presence of an oxidizer | BASF AKTIENGESELLSCHAFT (DE) | 1990-09-11 | — | — | US | disclosed |
| EP-0385330-A2 | Mixtures of dyestuffs comprising azo compounds on the basis of phenylox diazolyl aniline | BASF Aktiengesellschaft (DE) | 1990-09-05 | — | — | EP | disclosed |
| EP-0313965-A2 | Process for the manufacture of dihydroquinacridones, of quinacridones and of quinacridone quinones | BASF Aktiengesellschaft (DE) | 1989-05-03 | — | — | EP | disclosed |
| EP-0186977-A2 | Renin-inhibitory dipeptides, their preparation and use | SANKYO COMPANY LIMITED (JP) | 1986-07-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240092810-A1 | COMPOSITIONS FOR EXTREME ULTRAVIOLET LITHOGRAPHY AND RELATED METHODS | ALG3, VCL, ETV6 | TSHR 3896/4885THRB 3319/4885MEN1 610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.